Fragmento

The Female Patient 2012; 37(1): 11-16. Of the many unmet needs in the management of osteoporosis, perhaps the most fundamental is a general failure to identify patients at high risk for fracture who are likely to benefit from pharmacological intervention. To help identify patients at high risk for fracture, the National Osteoporosis Foundation (NOF) has developed comprehensive evidence-based clinical practice guideline for the prevention and treatment of osteoporosis. An important component of the NOF guidelines is the use of the World Health Organization (WHO) Fracture Risk Assessment Tool (FRAX) to provide a 10-year probability of fracture. (Additional information on the management of postmenopausal osteoporosis and FRAX is available in the 2010 Position Statement by The North American Menopause Society).

Palabras clave:

2013-04-17   |   309 visitas   |   1 valoraciones

Vol. 10 Núm.5. Septiembre-Octubre 2012 Pags. 189-192 Rev Metab Óseo y Min 2012; 10(5)